Aurion Biotech

Aurion Biotech

Verified
Advanced Therapies for Ocular Diseases

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$480—720m (Dealroom.co estimates Apr 2022.)
Seattle Washington (HQ)
  • Edit
DateInvestorsAmountRound
*
$120mEarly VC
Total Funding$120m

Recent News about Aurion Biotech

Edit